Insider · CIK 0001014094

BOWMAN JACK L

Reports to the SEC for 6 companies · PORTLAND, OR

sec.gov

Transactions

Companies

Filings

CIK

0001014094

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2007-09-17	CELGENE CORP /DE/Stock Option (right to buy)A Award	Director	AAward	+4,625 sh	—	—	4,625
2007-05-07	CELGENE CORP /DE/Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−40K sh	—	—	0
2007-05-07	CELGENE CORP /DE/S Sale	Director	SSale	−40K sh	$62.76	−$2.51M	12,000
2007-05-07	CELGENE CORP /DE/M Exercise/Conversion	Director	MExercise/Conversion	+40K sh	$8.40	+$336K	52,000
2006-07-31	CELGENE CORP /DE/M Exercise/Conversion	Director	MExercise/Conversion	+40K sh	$4.41	+$177K	52,000
2006-07-31	CELGENE CORP /DE/Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−40K sh	—	—	0
2006-07-31	CELGENE CORP /DE/S Sale	Director	SSale	−40K sh	$47.57	−$1.9M	12,000
2006-05-01	CELGENE CORP /DE/S Sale	Director	SSale	−40K sh	$41.94	−$1.68M	12,000
2006-05-01	CELGENE CORP /DE/M Exercise/Conversion	Director	MExercise/Conversion	+40K sh	$1.30	+$52.1K	52,000
2006-05-01	CELGENE CORP /DE/Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−40K sh	—	—	0
2006-03-17	SRPTSarepta Therapeutics, Inc.P Purchase	Director	PPurchase	+5,000 sh	$6.36	+$31.8K	5,000
2005-06-15	CELGENE CORP /DE/Stock Option (right to buy)A Award	Director	AAward	+3,750 sh	—	—	3,750
2005-05-26	ARMPArmata Pharmaceuticals, Inc. · Stock Option (right to buy)A Award	Director	AAward	+25K sh	—	—	25,000
2005-05-24	CELGENE CORP /DE/M Exercise/Conversion	Director	MExercise/Conversion	+20K sh	$1.77	+$35.4K	26,000
2005-05-24	CELGENE CORP /DE/S Sale	Director	SSale	−20K sh	$39.44	−$789K	6,000
2005-05-24	CELGENE CORP /DE/Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−20K sh	—	—	0
2005-05-18	SRPTSarepta Therapeutics, Inc. · Non-Qualified Stock Option (right to buy)A Award	Director	AAward	+10K sh	—	—	10,000
2004-12-15	CELGENE CORP /DE/Stock Option (right to buy)A Award	Director	AAward	+3,750 sh	—	—	3,750
2004-05-20	ARMPArmata Pharmaceuticals, Inc. · Stock Option (right to buy)A Award	Director	AAward	+20K sh	—	—	20,000
2004-04-21	CTI BIOPHARMA CORPNon-Qualified Stock Option (right to buy)A Award	Director	AAward	+10K sh	—	—	10,000
2003-11-06	DMK PHARMACEUTICALS CorpStock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−8,000 sh	—	—	0
2003-11-06	DMK PHARMACEUTICALS CorpStock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−20K sh	—	—	0
2003-11-06	DMK PHARMACEUTICALS CorpStock Option (right to buy)A Award	Director	AAward	+20K sh	—	—	20,000
2003-11-06	DMK PHARMACEUTICALS CorpStock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−1,000 sh	—	—	0
2003-11-06	DMK PHARMACEUTICALS CorpStock Option (right to buy)A Award	Director	AAward	+1,000 sh	—	—	1,000
2003-11-06	DMK PHARMACEUTICALS CorpStock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−17K sh	—	—	0
2003-11-06	DMK PHARMACEUTICALS CorpStock Option (right to buy)A Award	Director	AAward	+17K sh	—	—	17,000
2003-11-06	DMK PHARMACEUTICALS CorpStock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−8,000 sh	—	—	0
2003-11-06	DMK PHARMACEUTICALS CorpStock Option (right to buy)A Award	Director	AAward	+8,000 sh	—	—	8,000
2003-11-06	DMK PHARMACEUTICALS CorpStock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−8,000 sh	—	—	0
2003-11-06	DMK PHARMACEUTICALS CorpStock Option (right to buy)A Award	Director	AAward	+8,000 sh	—	—	8,000
2003-11-06	DMK PHARMACEUTICALS CorpStock Option (right to buy)A Award	Director	AAward	+8,000 sh	—	—	8,000
2003-11-06	DMK PHARMACEUTICALS CorpStock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−8,000 sh	—	—	0
2003-11-06	DMK PHARMACEUTICALS CorpStock Option (right to buy)A Award	Director	AAward	+8,000 sh	—	—	8,000
2003-11-06	DMK PHARMACEUTICALS CorpStock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−11.8K sh	—	—	0
2003-11-06	DMK PHARMACEUTICALS CorpStock Option (right to buy)A Award	Director	AAward	+11.8K sh	—	—	11,806
2003-11-06	DMK PHARMACEUTICALS CorpStock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−12K sh	—	—	0
2003-11-06	DMK PHARMACEUTICALS CorpStock Option (right to buy)A Award	Director	AAward	+12K sh	—	—	12,000
2003-11-06	DMK PHARMACEUTICALS CorpStock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−8,000 sh	—	—	0
2003-11-06	DMK PHARMACEUTICALS CorpStock Option (right to buy)A Award	Director	AAward	+8,000 sh	—	—	8,000
2003-09-15	CELGENE CORP /DE/Stock Option (right to buy)A Award	Director	AAward	+3,750 sh	—	—	3,750
2003-09-02	CELGENE CORP /DE/M Exercise/Conversion	Director	MExercise/Conversion	+10K sh	$3.54	+$35.4K	13,000
2003-09-02	CELGENE CORP /DE/S Sale	Director	SSale	−10K sh	$38.74	−$387K	3,000
2003-09-02	CELGENE CORP /DE/Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−10K sh	—	—	30,000
2003-08-07	PONIARD PHARMACEUTICALS, INC.P Purchase	Director	PPurchase	+2,000 sh	$2.49	+$4,980	21,500
2003-08-07	PONIARD PHARMACEUTICALS, INC.P Purchase	Director	PPurchase	+8,000 sh	$2.47	+$19.8K	19,500
2003-04-21	CTI BIOPHARMA CORPNon-Qualified Stock OptionA Award	Director	AAward	+5,000 sh	—	—	—
2003-01-31	PONIARD PHARMACEUTICALS, INC.Stock Option (Right to Buy)A Award	Director	AAward	+50K sh	—	—	—
2002-05-01	PONIARD PHARMACEUTICALS, INC.Stock Option (Right to Buy)A Award	Director	AAward	+10K sh	—	—	—
2002-05-01	PONIARD PHARMACEUTICALS, INC.Stock Option (Right to Buy)A Award	Director	AAward	+10K sh	—	—	—

Recent filings

Accepted (ET)
Sep 184
CELGENE CORP /DE/0000930413-07-007512
SEC(opens sec.gov)
May 94
CELGENE CORP /DE/0000930413-07-004268
SEC(opens sec.gov)
Aug 14
CELGENE CORP /DE/0000930413-06-005542
SEC(opens sec.gov)
May 34
CELGENE CORP /DE/0000930413-06-003486
SEC(opens sec.gov)
Mar 214
BOWMAN JACK L0001257957-06-000016
SEC(opens sec.gov)
Jun 164
BOWMAN JACK L0001012975-05-000186
SEC(opens sec.gov)
May 264
TARGETED GENETICS CORP /WA/0001209191-05-028536
SEC(opens sec.gov)
May 244
CELGENE CORP /DE/0001012975-05-000167
SEC(opens sec.gov)
May 194
AVI BIOPHARMA INC0001257957-05-000025
SEC(opens sec.gov)
Dec 164
BOWMAN JACK L0001012975-04-000289
SEC(opens sec.gov)
May 244
TARGETED GENETICS CORP /WA/0001209191-04-027616
SEC(opens sec.gov)
Apr 234
CELL THERAPEUTICS INC0000891293-04-000020
SEC(opens sec.gov)

Companies

Address

ONE SW COLUMBIA, SUITE 1105

PORTLAND, OR, 97258